한글목차

혈관성형술용 풍선 시장 규모는 2025년 28억 1,000만 달러에서 2034년에는 41억 3,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 4.38%로 성장할 전망입니다.

혈관성형술용 풍선 시장은 심혈관질환의 유병률 증가와 최소침습수술의 보급 확대를 배경으로 큰 폭의 성장이 예상됩니다. 전 세계적으로 고령화와 생활습관병이 증가함에 따라 효과적인 심장중재치료에 대한 수요가 급증하고 있습니다. 좁아지거나 막힌 동맥의 치료에 필수적인 혈관성형술용 풍선은 기존의 수술적 방법에 비해 덜 침습적인 대안으로 이러한 추세의 최전선에 위치하고 있습니다. 약물 용출형 풍선, 생체흡수성 소재 등 풍선 기술의 혁신으로 치료 효과와 환자의 예후가 개선되고 있습니다.

또한, 영상 진단 기술과 카테터 기술의 발달로 혈관성형술의 정확성과 안전성이 향상되고 있습니다. 실시간 영상 기술의 통합으로 혈관 구조에 대한 가시성이 향상되어 의료진이 보다 정확한 중재 시술을 할 수 있게 되었습니다. 이러한 추세는 정밀한 탐색이 필수적인 복잡한 케이스에서 특히 중요합니다. 또한, 환자 중심 의료에 대한 관심이 높아지면서 환자와 의료진 모두에게 시술 경험을 향상시킬 수 있는 사용하기 쉬운 기기들이 개발되고 있습니다.

예방의학 및 조기 개입에 대한 관심이 높아지면서 혈관성형술용 풍선 시장 성장에 기여하고 있습니다. 심혈관 건강에 대한 인식이 높아짐에 따라 더 많은 환자들이 적시에 치료 옵션을 찾고 있으며, 혈관성형술의 시행 건수가 증가하고 있습니다. 또한, 신흥시장의 의료 인프라 확충은 첨단 의료기술에 대한 접근성을 높여 시장 성장을 더욱 촉진하고 있습니다. 요약하면, 혈관성형술용 풍선 시장은 기술 혁신, 환자 치료 결과 개선, 증가하는 심혈관질환 부담에 대한 대응을 특징으로 하는 견고한 성장이 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 혈관성형술용 풍선 시장 : 제품별

제5장 세계의 혈관성형술용 풍선 시장 : 용도별

제6장 세계의 혈관성형술용 풍선 시장 : 최종 용도별

제7장 세계의 혈관성형술용 풍선 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Angioplasty Balloons Market size is expected to reach USD 4.13 Billion in 2034 from USD 2.81 Billion (2025) growing at a CAGR of 4.38% during 2026-2034.

The angioplasty balloons market is poised for significant growth, driven by the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. As the global population ages and lifestyle-related health issues become more prevalent, the demand for effective interventional cardiology solutions is surging. Angioplasty balloons, which are essential for treating narrowed or blocked arteries, are at the forefront of this trend, offering patients a less invasive alternative to traditional surgical methods. Innovations in balloon technology, such as drug-eluting balloons and bioresorbable materials, are enhancing treatment efficacy and patient outcomes.

Moreover, advancements in imaging and catheterization techniques are improving the precision and safety of angioplasty procedures. The integration of real-time imaging technologies allows for better visualization of vascular structures, enabling healthcare professionals to perform interventions with greater accuracy. This trend is particularly relevant in complex cases where precise navigation is critical. Additionally, the growing emphasis on patient-centered care is driving the development of user-friendly devices that enhance the overall procedural experience for both patients and healthcare providers.

The increasing focus on preventive healthcare and early intervention is also contributing to the growth of the angioplasty balloons market. As awareness of cardiovascular health rises, more patients are seeking timely treatment options, leading to an uptick in angioplasty procedures. Furthermore, the expansion of healthcare infrastructure in emerging markets is facilitating access to advanced medical technologies, further propelling market growth. In summary, the angioplasty balloons market is set for robust expansion, characterized by technological innovation, improved patient outcomes, and a commitment to addressing the growing burden of cardiovascular diseases.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Normal Balloons
• Drug Coated Balloons
• Cutting Balloons
• Scoring Balloons

By Application

• Peripheral Vascular Disease
• Coronary Vascular Disease
• By-End-use
• Ambulatory Surgical Centers
• Hospitals
• Cath Labs

COMPANIES PROFILED

• Medtronic, Boston Scientific Corporation, Johnson Johnson Services, Inc, Abbott, C R Bard, Inc, Spectranetics, Terumo Medical Corporation, Cardinal Health, Biotronik, Cook Medical, Endocor GmbH, B Braun SE

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANGIOPLASTY BALLOONS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Normal Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Drug Coated Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cutting Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Scoring Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANGIOPLASTY BALLOONS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Peripheral Vascular Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Coronary Vascular Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANGIOPLASTY BALLOONS MARKET: BY BY-END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast By-end-use
• 6.2. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cath Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANGIOPLASTY BALLOONS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By By-end-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By By-end-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By By-end-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By By-end-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By By-end-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ANGIOPLASTY BALLOONS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 Johnson & Johnson ServicesInc
  • 9.2.4 Abbott
  • 9.2.5 C. R. BardInc
  • 9.2.6 Spectranetics
  • 9.2.7 Terumo Medical Corporation
  • 9.2.8 Cardinal Health
  • 9.2.9 Biotronik
  • 9.2.10 Cook Medical
  • 9.2.11 Endocor GmbH
  • 9.2.12 B. Braun SE